Showing results (3181-3190 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|March 31, 2026
Allogeneic CD56 + cell infusion as a bridge to hematopoietic stem cell transplantation in relapsed/refractory acute myeloid leukemia: a phase I clinical trialAmin Shahbaz Ghasabeh, Amirhossein Izadpanah, Mehdi Bakhtiyaridovvombaygi, et al.Cancer Immunology, Immunotherapy : CII|March 31, 2026
An innovative treatment for lung cancer using gene-engineered human-induced pluripotent stem cell-derived natural killer cellsYuka Sato, Kumiko Goto, Shigehiro Yagishita, et al.Cancer Immunology, Immunotherapy : CII|April 28, 2026
Immunological impact of tumor-draining lymph node dissection on systemic Th1-like CD4+ T cells in patients with early-stage lung cancerAtsushi Kamigaichi, Hiroshi Kagamu, Yoshihiro Miyata, et al.Cancer Immunology, Immunotherapy : CII|April 28, 2026
Integrating single-cell and bulk transcriptomes to reveal prognostic and immunological features of ecDNA-related genes in osteosarcomaJinyan Feng, Jianchao Liu, Houzhi Yang, et al.Cancer Immunology, Immunotherapy : CII|March 24, 2026
Risk factors for immune checkpoint inhibitor colitis: a retrospective multi-center cohort study using electronic health recordsDanny Hoi Tsun Chu, Ann-Kathrin Schalkamp, Vivek A RudrapatnaCancer Immunology, Immunotherapy : CII|April 6, 2026
Hypoalbuminemia induces immunosuppression through disorder in macrophages and drives resistance to immune checkpoint inhibitorsFan Yang, Yaping Long, Yao Li, et al.Cancer Immunology, Immunotherapy : CII|April 6, 2026
Impact of immunochemotherapy administration sequence on overall survival in advanced esophageal and gastric cancers: a propensity score-matched multicenter analysisJunjie Hang, Lixia Wu, Li Xiao, et al.Cancer Immunology, Immunotherapy : CII|April 6, 2026
Compartment-specific GLUT1 patterns in colorectal liver metastases: invasive-margin GLUT1 associates with outcome in solitary diseaseEva Grießhammer, Niklas Bogovic, Edward K Geissler, et al.Cancer Immunology, Immunotherapy : CII|May 2, 2026
Evaluation of the predictive and prognostic potential of blood immune cell profiles in metastatic cancer patients treated with immune checkpoint inhibitorsVeera Nurmela, Anna-Mari Schroderus, Satu Tiainen, et al.Cancer Immunology, Immunotherapy : CII|April 21, 2026
KSR2 functions as a metabolic checkpoint for anti-PD-1 resistance by reprogramming glucose metabolismYuli Ge, Qiong Zhou, Qiangqiang Zhang, et al.Pageof 652